Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
424.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (0.939%)
Market Cap: £208.53m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Board Changes

29 Sep 2023 07:00

RNS Number : 0421O
Zotefoams PLC
29 September 2023
 

Zotefoams plc

('Zotefoams', the 'Company' or 'Group')

 

Board changes

29 September 2023 - Zotefoams (LSE: ZTF), a world leader in cellular materials technology, is pleased to announce the appointment of Malcolm Swift as a Non-Executive Director of the Company and Chair of the Remuneration Committee with effect from 29 September 2023, following a search process led by the Chair of the Company and supported by Korn Ferry. Malcolm will also join the Audit and Nomination Committees.

 

Malcolm is an Executive Vice President of McCormick & Co, a company listed on NYSE, from which he will retire at the end of 2023. He joined the company in 2005 and has held a series of executive positions, including President Global Flavour Solutions and Chief Administrative Officer. He is President of the European Brands Association, an organisation representing 2,500 businesses in Europe, from SMEs to multinationals and has held Non-Executive directorships with Devro plc and Stolt Sea Farm Holdings plc.

 

Zotefoams also announces that Dr Alison Fielding has informed the Board of her intention to step down as Non-Executive Director and Chair of the Remuneration Committee with effect from 29 September 2023 to devote more time to her other activities.

 

Commenting on Malcolm's appointment and Alison's departure, Dr Lynn Drummond, Chair of the Company commented:

 

"I am delighted to welcome Malcolm to the Zotefoams Board of Directors. His international experience and extensive B2B skill sets will support our growth agenda and he will be a valuable addition to the Board. I am looking forward to working with him.

 

"Ali leaves with our sincerest thanks for her insightful contribution to strategic and commercialisation issues. We also appreciate her leadership of the Remuneration Committee, including the recent shareholder consultation for our Remuneration Policy renewal, which received 97% approval. We wish her well for the future."

 

Malcolm Swift said: "Zotefoams' ambitious strategy, unique environmentally friendly technology and global markets present significant opportunities for growth. I am delighted to be part of the next stage of a business focused on delivering long-term, sustainable returns in the interests of all its stakeholders."

 

There is no further information which would require disclosure under LR9.6.13 of the Listing Rules of the Financial Conduct Authority.

 

 

Enquiries:

 

Zotefoams plc

+44 (0) 208 664 1600

David Stirling, Group CEO

Gary McGrath, Group CFO

 

 

IFC Advisory

+44 (0) 203 934 6630

Graham Herring

Tim Metcalfe

Zach Cohen

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce® mono-material recyclable barrier packaging.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA, Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA, Stilling, Denmark (microcellular foam technology) and Jiangsu Province, China (T-FIT).

www.zotefoams.com

AZOTE®, ZOTEK®, ReZorce® and T-FIT® are registered trademarks of Zotefoams plc.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABXGDCSBDDGXI
Date   Source Headline
4th Aug 20097:00 amRNSHalf Yearly Report
20th Jul 20091:42 pmRNSHolding(s) in Company
3rd Jul 20097:00 amRNSTrading Statement
17th Jun 20095:33 pmRNSHolding(s) in Company
5th Jun 200912:23 pmRNSDirector/PDMR Shareholding
19th May 200910:30 amRNSAnnual Information Update
12th May 200910:30 amRNSVoting Rights and Capital
7th May 20097:00 amRNSAGM Statement
7th Apr 200910:51 amRNSNotice of AGM
26th Mar 20097:00 amRNSAdditional Listing
18th Mar 20091:50 pmRNSDirector/PDMR Shareholding
16th Mar 20095:19 pmRNSDirector/PDMR Shareholding
10th Mar 20097:00 amRNSFinal Results
22nd Jan 200911:36 amRNSHolding(s) in Company
5th Jan 20091:19 pmRNSVoting Rights and Capital
19th Dec 20087:00 amRNSTrading Statement
12th Dec 200811:04 amRNSDirector/PDMR Shareholding
11th Dec 20082:20 pmRNSHolding(s) in Company
3rd Nov 20087:00 amRNSInterim Management Statement
30th Oct 20082:25 pmRNSAdditional Listing
14th Aug 20087:00 amRNSDirector/PDMR Shareholding
5th Aug 20087:00 amRNSInterim Results
9th Jul 20089:11 amRNSAcquires Stake
1st Jul 20087:00 amRNSTrading Update
5th Jun 20089:37 amRNSVoting rights and capital
23rd May 20085:38 pmRNSAnnual Information Update
8th May 20087:01 amRNSAGM Statement
14th Apr 20087:00 amRNSBlocklisting Interim Review
8th Apr 20086:07 pmRNSAdditional Listing
8th Apr 20088:18 amRNSNotice of AGM
25th Mar 20082:46 pmRNSDirector/PDMR Shareholding
4th Mar 20087:01 amRNSFinal Results
3rd Mar 20087:00 amRNSCustomer Achievement
1st Feb 20081:46 pmRNSTotal Voting Rights
21st Dec 20072:48 pmRNSDirectors' Shareholdings
26th Nov 200710:04 amRNSAdditional Listing
12th Nov 20077:01 amRNSDirector/PDMR Shareholding
7th Nov 20078:45 amRNSDirectors' Shareholdings
30th Oct 20072:55 pmRNSHolding in Company
19th Oct 20077:01 amRNSProduct Achievement
17th Oct 20079:32 amRNSBlocklisting Interim Review
5th Sep 200712:29 pmRNSHolding(s) in Company
28th Aug 20077:02 amRNSMarketing Alliance
7th Aug 20077:00 amRNSInterim Results
30th Jul 20074:45 pmRNSVoting rights & capital
12th Jul 20074:02 pmRNSDirectorate Change
29th Jun 200711:04 amRNSTrading Update
28th Jun 20072:23 pmRNSHolding(s) in Company
21st May 200712:03 pmRNSAnnual Information Update
17th May 20079:14 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.